Epi Profile Section 11 - References

1. Centers for Disease Control and Prevention (CDC). Report of Verified Case of Tuberculosis Instruction Manual, 2009. Atlanta, GA: US Department of Health and Human Services, CDC; 2019.
    
2. Centers for Disease Control and Prevention (CDC). Reported Tuberculosis in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2020.
    
3. World Health Organization (WHO), Tuberculosis, 2019. Accessed at who.int/news-room/fact-sheets/detail/tuberculosis.
    
4. Online Tuberculosis Information System (OTIS), National Tuberculosis Surveillance System, United States, 1993-2019. U.S. Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), Division of TB Elimination, CDC WONDER Online Database, October 2019. Data for all years updated by June 1, 2020. Accessed at wonder.cdc.gov/tb-v2019.html on September 28, 2020 11:52:36 AM.
    
5. France AM, Grant J, Kammerer JS, Navin TR. A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States. Am J Epidemiol 2015; 182: 799-807.
    
6. Centers for Disease Control and Prevention (CDC). The Costly Burden of Drug Resistant TB Disease in the U.S. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. 

Table of Contents | An Overview of Tuberculosis in Texas | Geographic Distribution of Tuberculosis in Texas | Affected Populations | Case Diagnosis | Recent Transmission | Mortality | Risk Factors Associated with Tuberculosis | Drug Resistant TB | Public Health Follow-Up Outcomes | Reporting Requirements | References